# A Trial of MHB088C in Advanced Extrapulmonary Neuroendocrine Cancer

> **NCT06951243** · PHASE2 · NOT_YET_RECRUITING · sponsor: **Beijing GoBroad Hospital** · enrollment: 40 (estimated)

## Conditions studied

- Advanced Extrapulmonary Neuroendocrine Cancer

## Interventions

- **DRUG:** MHB088C for Injection (B7-H3 ADC)

## Key facts

- **NCT ID:** NCT06951243
- **Lead sponsor:** Beijing GoBroad Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-05-06
- **Primary completion:** 2026-05-06
- **Final completion:** 2028-05-06
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2025-04-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06951243

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06951243, "A Trial of MHB088C in Advanced Extrapulmonary Neuroendocrine Cancer". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06951243. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*